Coloff Jonathan L, Rathmell Jeffrey C
Department of Pharmacology and Cancer Biology, Sarah W. Stedman Nutrition and Metabolism Center, and 2Department of Immunology, Duke University Medical Center, Durham, NC 27710.
J Cell Biol. 2006 Dec 18;175(6):845-7. doi: 10.1083/jcb.200610119. Epub 2006 Dec 11.
The respiration-deficient, highly glycolytic metabolic phenotype of cancer cells known as the "Warburg effect" has been appreciated for many years. A new study (see Pelicano et al. on p. 913 of this issue) demonstrates that respiration deficiency caused by mitochondrial mutation or hypoxia may directly promote the enormous survival advantage observed in cancer cells by activation of the phosphatidylinositol 3-kinase-Akt survival pathway. We discuss these and other recent findings that show how metabolic changes associated with cancer can play a significant role in tumor biology.
癌细胞呼吸缺陷、高度糖酵解的代谢表型即所谓的“瓦伯格效应”已被认识多年。一项新的研究(见本期第913页佩利卡诺等人的文章)表明,由线粒体突变或缺氧引起的呼吸缺陷可能通过激活磷脂酰肌醇3-激酶-蛋白激酶B生存途径,直接促进癌细胞中观察到的巨大生存优势。我们将讨论这些以及其他最近的发现,这些发现表明与癌症相关的代谢变化如何在肿瘤生物学中发挥重要作用。